PRESS RELEASE published on 06/13/2025 at 01:00, 5 months 22 days ago BioNxt Solutions Provides Bi-Weekly MCTO Status Report BioNxt Solutions provides an update on the management cease trade order from BCSC, ensuring efforts to file required financial documents by June 30, 2025 Management Cease Trade Order BCSC Filing Deadline Financial Documents BioNxt Solutions
BRIEF published on 05/30/2025 at 01:05, 6 months 6 days ago BioNxt Solutions met à jour le statut de l'ordonnance de cessation d'opérations de la direction MCTO BCSC Solutions BioNxt Dépôt De Documents Financiers Progression De L'audit
BRIEF published on 05/30/2025 at 01:05, 6 months 6 days ago BioNxt Solutions Updates on Management Cease Trade Order Status MCTO Financial Filing BCSC BioNxt Solutions Audit Progress
PRESS RELEASE published on 05/30/2025 at 01:00, 6 months 6 days ago BioNxt Solutions Provides Bi-weekly MCTO Status Report BioNxt Solutions Inc. announces management cease trade order by BCSC until required financial statements are filed. Company's progress on compliance and commitment to regulation outlined Financial Statements Regulatory Compliance Management Cease Trade Order BCSC BioNxt Solutions Inc.
BRIEF published on 05/23/2025 at 09:10, 6 months 13 days ago BioNxt Solutions s'apprête à obtenir un brevet européen pour son système d'administration de médicaments Sclérose En Plaques Développement De Médicaments Solutions BioNxt Brevet Européen Administration Sublinguale
BRIEF published on 05/23/2025 at 09:10, 6 months 13 days ago BioNxt Solutions Set to Receive European Patent for Drug Delivery System Drug Development Multiple Sclerosis European Patent BioNxt Solutions Sublingual Delivery
PRESS RELEASE published on 05/23/2025 at 09:05, 6 months 13 days ago BioNxt Solutions Reports Formal Notice from the European Patent Office of Intention to Grant Patent BioNxt Solutions Inc. announces European Patent Office's intention to grant their core patent for advanced drug delivery systems, focusing on sublingual anticancer treatments BioNxt Solutions Inc. European Patent Office Drug Delivery Systems Sublingual Anticancer Treatments
BRIEF published on 05/16/2025 at 01:35, 6 months 20 days ago BioNxt Solutions fournit une mise à jour du statut MCTO MCTO États Financiers Conformité Réglementaire Processus D'audit Informations Aux Actionnaires
BRIEF published on 05/16/2025 at 01:35, 6 months 20 days ago BioNxt Solutions Provides MCTO Status Update Financial Statements Regulatory Compliance Shareholder Information MCTO Audit Process
PRESS RELEASE published on 05/16/2025 at 01:30, 6 months 20 days ago Bionxt Solutions Provides Bi-Weekly MCTO Status Report BioNxt Solutions Inc. announces a management cease trade order granted by the BC Securities Commission affecting the CEO and CFO from trading until Required Documents filed by June 30, 2025 Management Cease Trade Order BioNxt Solutions Inc. Filing Deadline BC Securities Commission Required Documents
Published on 12/05/2025 at 17:15, 54 minutes ago TRX GOLD Attending the 3rd Annual DealFlow Discovery Conference
Published on 12/05/2025 at 17:00, 1 hour 9 minutes ago Three Trillion-Dollar Frontiers, One Technology: How SMX Is Everywhere at Once
Published on 12/05/2025 at 16:00, 2 hours 9 minutes ago SMX Didn't Change Its Story; The World Finally Connected the Dots
Published on 12/05/2025 at 15:45, 2 hours 24 minutes ago Critical Elements announce la clôture d'un placement privé de 7,0 $ million ca par voie de prise ferme
Published on 12/05/2025 at 15:45, 2 hours 24 minutes ago Critical Elements Announces Closing of C$7.0 Million Bought Deal Life Private Placement
Published on 12/05/2025 at 17:46, 23 minutes ago Booster Precision Components Holding GmbH announces the successful completion of its Written Procedure to amend and waive certain terms under the terms and conditions of the Bonds
Published on 12/05/2025 at 17:00, 1 hour 9 minutes ago EQS-Adhoc: The NAGA Group AG adjusts guidance for financial year 2025 following continued low volatility and weaker year-end performance
Published on 12/05/2025 at 16:25, 1 hour 44 minutes ago 4YFN26 Awards: Meet the Top 20 startups building the future
Published on 12/05/2025 at 16:10, 1 hour 59 minutes ago Reorganization of the Eckert & Ziegler Executive Board
Published on 12/05/2025 at 17:18, 51 minutes ago La vidéo de la réunion de présentation des résultats 2024-2025 du 5 décembre 2025 est disponible
Published on 12/05/2025 at 17:18, 51 minutes ago The video of the 2024-2025 results presentation meeting on December 5, 2025, is available
Published on 12/05/2025 at 15:10, 2 hours 58 minutes ago Mersen: Number of shares and voting rights as of November 30, 2025
Published on 12/05/2025 at 15:10, 2 hours 58 minutes ago Mersen : nombre d'actions et de droits de vote au 30 novembre 2025
Published on 12/05/2025 at 13:58, 4 hours 11 minutes ago RELATIF A LA MISE A DISPOSITION DU PUBLIC DE LA NOTE D'INFORMATION ET DES INFORMATIONS RELATIVES AUX CARACTERISTIQUES, NOTAMMENT JURIDIQUES, FINANCIERES ET COMPTABLES DE LEGRAND FRANCE
